Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01032824 · ClinicalTrials.gov registry record · NA

Self-Managing HIV and Chronic Disease

A NA study, sponsored by Kaiser Permanente.

Completed
Registry status
NA
Development phase
452
Enrollment target

NCT01032824: Completed NA study, sponsored by Kaiser Permanente.

NCT01032824 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 452 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01032824, a NA study, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
NA
Development phase
452 participants
Enrollment target

Study Summary

The purpose of this study is to conduct a randomized control trial of a behavioral intervention delivered by counselors via telephone to determine if this is an efficacious method for improving medication adherence and health-related quality of life for persons who are 50 and older and living with HIV/AIDS and other chronic conditions.

Interventions

  • BEHAVIORAL Individual Telephone Counseling Intervention
  • OTHER Group Arm
  • OTHER Book Arm

Trial Details

FieldValue
Enrollment Target 452 participants
Start Date 2007-10
Est. Completion 2011-02
Phase NA
Kaiser Permanente

294 total trials

What the finished NCT01032824 record still lists

NCT01032824 is an interventional study that assigns participants to a tested intervention. The registered 452 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).

The record links to 0 conditions, and to 3 interventions - of which Individual Telephone Counseling Intervention is the first listed.

NCT01032824 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01032824 about?

NCT01032824 is a clinical study titled "Self-Managing HIV and Chronic Disease". The purpose of this study is to conduct a randomized control trial of a behavioral intervention delivered by counselors via telephone to determine if this is an efficacious method for improving medication adherence and health-related quality of life for persons who are 50 and older and living with H...

What is the current status of trial NCT01032824?

This trial is currently completed. It is a NA study. The enrollment target is 452 participants. The study started on 2007-10. Estimated completion is 2011-02.

What interventions are being tested in trial NCT01032824?

The interventions under investigation include: Individual Telephone Counseling Intervention (BEHAVIORAL), Group Arm (OTHER), Book Arm (OTHER).

Who is sponsoring clinical trial NCT01032824?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01032824's enrollment target sits among peer trials

452 225th of 2000 higher than 1,776 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05676255 · 452 participants · Phase 2

    The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project

  • NCT05703178 · 452 participants · Phase 3

    Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia

  • NCT03460977 · 453 participants · Phase 1

    A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

  • NCT04708171 · 453 participants

    The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01032824, the US trial registry maintained by the National Library of Medicine. NCT01032824 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.